Abbott Laboratories (ABT) Finished Goods (2016 - 2026)

Abbott Laboratories' Finished Goods history spans 18 years, with the latest figure at $4.3 billion for Q1 2026.

On a quarterly basis, Finished Goods rose 5.19% to $4.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.3 billion, a 5.19% increase, with the full-year FY2025 number at $4.0 billion, up 7.46% from a year prior.
Finished Goods hit $4.3 billion in Q1 2026 for Abbott Laboratories, up from $4.0 billion in the prior quarter.
Over the last five years, Finished Goods for ABT hit a ceiling of $4.3 billion in Q2 2025 and a floor of $3.4 billion in Q3 2022.
Historically, Finished Goods has averaged $3.9 billion across 5 years, with a median of $4.0 billion in 2025.
Biggest five-year swings in Finished Goods: increased 23.5% in 2022 and later fell 6.23% in 2024.
Tracing ABT's Finished Goods over 5 years: stood at $3.8 billion in 2022, then rose by 3.71% to $3.9 billion in 2023, then dropped by 6.23% to $3.7 billion in 2024, then rose by 7.46% to $4.0 billion in 2025, then increased by 7.49% to $4.3 billion in 2026.
Business Quant data shows Finished Goods for ABT at $4.3 billion in Q1 2026, $4.0 billion in Q4 2025, and $4.1 billion in Q3 2025.

Peer Comparison